Philosys has received U.S. FDA (FDA) 510K approval for its Gmate SMART Blood Glucose Monitoring System.
The Gmate SMART meter is the size of a quarter and connects to the headphone jack on the iPhone, iPod touch or iPad, while using the free Gmate SMART app to deliver blood glucose test results.
Said application and meter integrate diabetes management directly to an iOS device while providing the following features: goal setting, graphing, and the ability to email or text blood glucose test results directly to a healthcare provider.
According to Center for Technology Innovation at Brookings, chronic diseases such as diabetes are costly and taxing on the current system. The use of mobile technologies that monitor patient symptoms and provide real-time treatment options have the potential to control costs, reduce errors, and improve the overall patient experience.
Chronic diseases such as diabetes are costly and taxing on the current system.“This is an exciting time for Philosys as we continue our efforts to be a technology leader for the diabetes mobile monitoring arena,” said Mike Tickle, Senior VP of Philosys’ Sales. “The Gmate SMART will give our customers TeleHealth capabilities with the accuracy and quality they deserve at a cost effective price.”
Philosys continues to move forward in their commitment to providing innovative health solutions to people with diabetes around the world.